Summary of Key Points Core Viewpoint - The report outlines the continuous supervision activities conducted by Huatai United Securities for Qu Mei Home Group Co., Ltd. in 2024, confirming compliance with regulatory requirements and the absence of significant violations. Group 1: Continuous Supervision Activities - Huatai United Securities has established and effectively implemented a continuous supervision work system and corresponding work plan [1] - The sponsor has signed a continuous supervision agreement with the company, clarifying rights and obligations during the supervision period [1] - During the supervision period, there were no violations or illegal activities reported by Qu Mei Home [1][2] Group 2: Internal Control and Governance - The company has been urged to establish and effectively implement internal control systems, including financial management and accounting [2] - Continuous supervision has ensured that the company and its management comply with laws, regulations, and commitments made [1][2] - The governance structure, including rules for shareholder meetings and board meetings, has been effectively established and executed [2] Group 3: Information Disclosure - Huatai United Securities has reviewed the company's information disclosure documents, ensuring they are truthful, accurate, and complete without any misleading statements or omissions [4] - The company has adhered to the relevant regulations for information disclosure, ensuring timely and effective public reporting of significant information [4] - There were no instances requiring reporting to the China Securities Regulatory Commission or the Shanghai Stock Exchange regarding violations of disclosure regulations [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 山东威高血液净化制品股份有限公司（以下简称"威高血净"、"发行人"或"公司"）首次公开发行人民币 普通股（A股）并在主板上市（以下简称"本次发行"）的申请已经上海证券交易所（以下简称"上交 所"）上市审核委员会审议通过，并已经中国证券监督管理委员会（以下简称"中国证监会"）同意注册 （证监许可〔2025〕526号）。本次发行的保荐人（主承销商）为华泰联合证券有限责任公司（以下简 称"华泰联合证券"、"保荐人（主承销商）"）。 经发行人和保荐人（主承销商）协商确定本次发行股份数量为4,113.9407万股，全部为公开发行新股。 本次发行中，网上向持有上海市场非限售A股股份和非限售存托凭证市值的社会公众投资者定价发行与 网下向符合条件的网下投资者询价配售将于2025年5月8日（T日）分别通过上交所交易系统和上交所互 联网交易平台（IPO网下询价申购）（以下简称"互联网交易平台"）实施。 发行人和保荐人（主承销商）特别提请投资者关注以下内容： 1、本次发行采用向参与战略配售的投资者定向配售（以下简称"战略配售"）、网下向符合条件的网下 投资者询价配售（以下简称"网下 ...

Group 1 - The core viewpoint of the news is the successful issuance of the second phase of non-public corporate bonds by Xi'an Urban Development Group Co., Ltd., aimed at professional investors, with a total scale of 1 billion yuan and a term of 3 years at a coupon rate of 2.25% [1] - The bond issuance was oversubscribed with a subscription multiple of 4.06 times, marking the first "laboratory economy" technology innovation corporate bond on the Shanghai Stock Exchange [1] - The laboratory economy is defined as a technology innovation model that promotes the integration of technology and finance, enhancing economic development through the commercialization of key technology products [1] Group 2 - The funds raised from this bond issuance will be entirely used for equity investment in Shaanxi Chang'an Pilot Industry Innovation Center Co., Ltd., a new type of R&D institution approved by the Xi'an municipal government [2] - The Chang'an Pilot Industry Innovation Center aims to accelerate the transformation and application of scientific research results, thereby promoting technological innovation and industrial upgrading in Xi'an and nationwide [2] - The bond issuance is expected to contribute to the cultivation of new productive forces and support high-quality economic development [2]

Financial Performance - In 2024, the company reported a revenue of 591.94 million yuan, a decrease of 14.85% compared to 2023 [1][2] - The net profit attributable to shareholders was -256.12 million yuan, down from a profit of 32.28 million yuan in the previous year [1][2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -261.38 million yuan, compared to 25.45 million yuan in 2023, marking a decline of 1,126.89% [1][2] - The net cash flow from operating activities was -67.63 million yuan [1][2] Q1 2025 Performance - For the first quarter of 2025, the company achieved a revenue of 101 million yuan, a year-on-year decline of 17.43% [1][2] - The net profit attributable to shareholders for Q1 2025 was -17.43 million yuan, compared to -11.85 million yuan in the same period last year [1][2] - The net profit after deducting non-recurring gains and losses was -17.96 million yuan, down from -13.03 million yuan in Q1 2024 [1][2] - The net cash flow from operating activities for Q1 2025 was -94.06 million yuan [1][2] Company Background - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 14, 2021, with an initial offering price of 39.50 yuan per share [4] - The total funds raised from the initial public offering amounted to 1.362 billion yuan, with a net amount of 1.24 billion yuan after deducting issuance costs [4] - The company planned to use the raised funds for various projects, including the development of specialized electronic medical records and upgrading data centers [4]

Core Viewpoint - The stock of Artes (688472.SH) is currently trading at 8.84 yuan, reflecting a decline of 4.43% and is in a state of underperformance since its IPO [1] Group 1: IPO Details - Artes was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 9, 2023, with an initial public offering (IPO) price of 11.10 yuan per share [1] - The total number of shares issued before the exercise of the over-allotment option was 541,058,824, representing 15.00% of the post-issue total share capital; after full exercise, the number of shares increased to 622,217,324, accounting for 16.87% [1] - The total amount raised from the IPO was 600,575.29 million yuan before the over-allotment option and 690,661.23 million yuan after full exercise [1] Group 2: Fund Utilization and Financials - The net amount raised after deducting issuance costs was 572,782.43 million yuan before the over-allotment option and 662,845.46 million yuan after full exercise [1] - The final net amount raised exceeded the original plan by 172,782.43 million yuan before the over-allotment option and 262,845.46 million yuan after full exercise [2] - The company planned to use the raised funds for capacity expansion projects, the establishment of a research institute, and to supplement working capital [2] Group 3: Underwriting and Shareholding - The total underwriting fees and sponsorship costs amounted to 27,792.86 million yuan before the over-allotment option and 27,815.77 million yuan after full exercise [2] - The underwriting team included China International Capital Corporation, Huatai United Securities, and Dongwu Securities, which collectively received 17,264.15 million yuan in fees [2] - The actual controllers of Artes are Xiaohua Qu and his spouse Han Bing Zhang, both of whom hold Canadian nationality [2]

证券代码：603189 证券简称：网达软件 公告编号：2025-018 上海网达软件股份有限公司 关于变更部分募集资金专户及重新签订 募集资金专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海网达软件股份有限公司（以下简称"公司"）于2025年4月12日召开第五届董事会第二次会议、第五 届监事会第二次会议，审议通过了《关于变更部分募集资金专项账户的议案》，公司于近日已完成变更 募集资金专项账户（以下简称"募集资金专户"）并签署了《募集资金专户存储三方监管协议》，具体情 况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准上海网达软件股份有限公司非公开发行股票的批复》（证监许可 〔2020〕2267号文）文件核准，公司以非公开方式向10名特定对象发行人民币普通股(A股)48,748,349 股，每股发行价格为15.18元，募集资金总额为人民币739,999,937.82元，扣除发行费用人民币 9,846,380.45元（不含增值税），募集资金净额为人民币730,153,557.37元。 ...

中国经济网北京4月17日讯方邦股份(688020.SH)昨日晚间公布2024年年度报告显示，公司2024年实现营 业收入3.44亿元，同比下降0.17%；归属于上市公司股东的净利润-9164.27万元；归属于上市公司股东的 扣除非经常性损益的净利润-1.13亿元；经营活动产生的现金流量净额-4596.77万元。 方邦股份发行费用总计为9,856.04万元(不含增值税)，其中华泰联合证券有限责任公司获得承销及保荐 费7,776.60万元。 2022年、2023年，方邦股份归属于上市公司股东的净利润分别为-6802.42万元、-6867.01万元；归属于 上市公司股东的扣除非经常性损益的净利润分别为-8212.76万元、-8585.15万元。 | 单位 币种: 元 | | --- | | 人民币 | | 主要会计 | 2024年 | 2023年 | 本期比 上年同 | 2022年 | | | --- | --- | --- | --- | --- | --- | | 数据 | | | 期增减 | 调整后 | 调整前 | | | | | (%) | | | | 营业收入 扣除与主 | 344.570.817.57 ...

江苏江顺精密科技集团股份有限公司(以下简称"发行人"、"江顺科技"或"公司")首次公开发行股票并在主板上市申 请已经深圳证券交易所(以下简称"深交所")上市审核委员会审议通过,并已经中国证券监督管理委员会同意注册(证 监许可[2025]608号)。 本次发行采用直接定价方式,全部股份通过网上向持有深圳市场非限售A股股份和非限售存托凭证市值(以下简称"市 值")的社会公众投资者定价发行(以下简称"网上发行"),不进行网下询价和配售。本次发行数量1,500.00万股,其中网 上发行数量为1,500.00万股,占本次发行总量的100%。本次发行股份全部为新股,不转让老股。本次发行的股票无流 通限制及锁定安排。 为了便于投资者了解发行人的有关情况、发展前景和本次发行申购的相关安排,发行人和本次发行的保荐人(主承销 商)华泰联合证券有限责任公司(以下简称"保荐人(主承销商)")定于2025年4月14日举行网上路演,敬请广大投资者关 注。 本次发行的招股说明书全文及相关资料可在中国证监会指定网站(巨潮资讯网,网址www.cninfo.com.cn;中证网,网址 www.cs.com.cn;中国证券网,网址www.cnst ...

Core Points - The company reported a revenue of 1.378 billion yuan for 2024, representing a year-on-year growth of 7.15% [1][3] - The net profit attributable to shareholders was -18.09 million yuan, an improvement from -70.96 million yuan in the previous year [1][3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -83.22 million yuan, compared to -192.74 million yuan in the previous year [1][3] - The net cash flow from operating activities was -9.68 million yuan, a significant decline from 152.99 million yuan in the previous year [1][3] - The company plans to distribute a cash dividend of 1.50 yuan per 10 shares, totaling approximately 59.66 million yuan [1] Financial Data Summary - Revenue for 2024 was 1.378 billion yuan, up from 1.286 billion yuan in 2023, marking a 7.15% increase [3] - The net profit attributable to shareholders improved from -70.96 million yuan in 2023 to -18.09 million yuan in 2024 [3] - The net profit after excluding non-recurring items improved from -192.74 million yuan in 2023 to -83.22 million yuan in 2024 [3] - The net cash flow from operating activities decreased from 152.99 million yuan in 2023 to -9.68 million yuan in 2024, a decline of 106.33% [3] IPO and Fundraising Information - The company raised a total of 2.201 billion yuan from its initial public offering, with a net amount of 2.109 billion yuan after deducting issuance costs [4] - The final net fundraising amount exceeded the original plan by 907 million yuan [4] - The funds raised are intended for the establishment of a new headquarters and R&D base, expansion of the marketing network, and to supplement working capital [4]

Group 1 - The company, Qingyuan Technology Co., Ltd., is issuing convertible bonds totaling RMB 500 million, with a bond code of 113694 and a bond name of Qingyuan Convertible Bonds [1][19][30] - The issuance date is set for April 8, 2025, with a subscription period from 9:30 to 11:30 and 13:00 to 15:00 [1][5][29] - The bonds will have a face value of RMB 100 each and will be issued at par [20][30] Group 2 - The bonds will have a maturity period of six years, from April 8, 2025, to April 7, 2031, with annual interest payments [20][21] - The coupon rates are structured to increase over the years, starting at 0.20% in the first year and reaching 2.50% in the sixth year [20][21] - The initial conversion price is set at RMB 12.93 per share, which is based on the average trading price of the company's stock prior to the announcement [21][22] Group 3 - Original shareholders will have priority in subscribing to the bonds, with a subscription ratio of 0.001827 bonds per share held [6][12][32] - The total number of shares eligible for priority subscription is 273,622,100, allowing for a maximum of 500,000 hands of bonds to be allocated to original shareholders [6][12][32] - Any remaining bonds after the priority subscription will be offered to the public through an online subscription process [4][14][29] Group 4 - The underwriting will be managed by Huatai United Securities Co., Ltd., which will also handle any unsold bonds [1][10][30] - The company will announce the results of the subscription and the allocation of bonds on April 9, 2025 [8][30] - Investors must ensure their accounts have sufficient funds by April 10, 2025, to cover their subscriptions [8][30]